Last reviewed · How we verify
NCT07418151: CHOCO-NST
Effect of Maternal Chocolate Consumption on Fetal Non-Stress Test (NST) Reactivity.
NA trial testing Dark Chocolate in Fetal Distress in 190 participants. Currently enrolling.
31 August 2026
Quick facts
| Lead sponsor | Universidad Nacional Autonoma de Honduras |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 190 |
| Start date | 15 February 2026 |
| Primary completion | 31 August 2026 |
| Estimated completion | 30 September 2026 |
| Sites | 1 location across Honduras |
Drugs / interventions tested
- Dark Chocolate — full drug profile →
- Sugar-free White Chocolate
Conditions studied
- Fetal Distress — all drugs for Fetal Distress →
Sponsor
Universidad Nacional Autonoma de Honduras — full company profile →
Who can join
Adults 18 to 49, female only, with Fetal Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-blind, randomized, parallel-group, superiority clinical trial. The study aims to determine whether a single intake of 30g of dark chocolate (≥80% cocoa) by pregnant women with a non-reactive fetal non-stress test (NST) increases the conversion rate to a reactive NST within 20 minutes, compared to observation with a sugar-free white chocolate placebo. A total of 190 singleton pregnant women at 36-41 weeks gestation with a non-reactive NST will be recruited at the Hospital General San Felipe, Tegucigalpa, Honduras. Participants will be randomly assigned to either the intervention group (dark chocolate) or the control group (placebo). The primary outcome is the proportion of NSTs that become reactive. Secondary outcomes include changes in specific cardiotocographic parameters, total monitoring time, need for additional tests, and maternal satisfaction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07418151
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dark Chocolate
Trials testing the same drug.
- NCT05290012 — The Effect of Dark Chocolate Consumption on Blood Parameters in Healthy Adult Individuals · NA · completed
- NCT04600258 — Chocolate for Patients With Chronic Kidney Disease · NA · completed
- NCT03850405 — Dark Chocolate, Cholesterol and Microbiota · NA · unknown
- NCT03195465 — The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder · NA · terminated
- NCT02764203 — ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial · NA · completed
Other recruiting trials for Fetal Distress
Currently open trials in the same condition.
- NCT05681624 — Maternal Oxygen Supplementation for Intrauterine Resuscitation · NA · recruiting
- NCT06186973 — Fetal Assessment of the Myocardium and Evaluation of the Neonate · recruiting
Other Universidad Nacional Autonoma de Honduras trials
Trials by the same sponsor.
- NCT07428317 — Use of Lubricant Gel to Shorten the Second Stage of Labor During Vaginal Delivery · NA · recruiting
- NCT07440069 — Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor · Phase 4 · recruiting
- NCT07411352 — Left Lateral Position vs Supine Position to Reduce Active Labor Duration · NA · recruiting
- NCT07401160 — Umbilical Cord Drainage to Prevent Postpartum Hemorrhage · NA · recruiting
- NCT06759350 — Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07418151 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Nacional Autonoma de Honduras
- Last refreshed: 3 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07418151.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing